JASMINE WASHINGTON: Open Payments
NPI 1780207258 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 17 payments from 9 companies in 2025. Trend: 2023 $423 · 2024 $492 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| Exact Sciences Corporation | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Novo Nordisk Inc | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $26 |
| Dexcom, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, The Cologuard Plus Collection Kit, TZIELD, GEMTESA, NURTEC ODT, Cologuard Collection Kit, Rybelsus.
Industry payments across SC — which companies pay providers there.
